REFERENCES
1. World Health Organization. Telemedicine: opportunities and developments in Member States: report on the second global survey on eHealth 2009; 2010. Available from: https://www.cabdirect.org/cabdirect/abstract/20133159246 [Last accessed on 28 Jun 2022].
2. Haleem A, Javaid M, Singh RP, Suman R. Telemedicine for healthcare: capabilities, features, barriers, and applications. Sens Int 2021;2:100117.
4. Snoswell CL, Chelberg G, De Guzman KR, et al. The clinical effectiveness of telehealth: a systematic review of meta-analyses from 2010 to 2019. J Telemed Telecare 2021:1357633X211022907.
5. Kitsiou S, Paré G, Jaana M. Effects of home telemonitoring interventions on patients with chronic heart failure: an overview of systematic reviews. J Med Internet Res 2015;17:e63.
6. Kotb A, Cameron C, Hsieh S, Wells G. Comparative effectiveness of different forms of telemedicine for individuals with heart failure (HF): a systematic review and network meta-analysis. PLoS One 2015;10:e0118681.
7. Battineni G, Sagaro GG, Chintalapudi N, Amenta F. The benefits of telemedicine in personalized prevention of Cardiovascular Diseases (CVD): a systematic review. J Pers Med 2021;11:658.
8. Omboni S, Campolo L, Panzeri E. Telehealth in chronic disease management and the role of the Internet-of-Medical-Things: the Tholomeus® experience. Expert Rev Med Devices 2020;17:659-70.
9. Fisher NDL, Curfman G. Hypertension-a public health challenge of global proportions. JAMA 2018;320(17):1757-9.
10. Zhou B, Carrillo-larco RM, Danaei G, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet 2021;398:957-80.
11. Omboni S, Panzeri E, Campolo L. E-Health in hypertension management: an insight into the current and future role of blood pressure telemonitoring. Curr Hypertens Rep 2020;22:42.
12. Omboni S, McManus RJ, Bosworth HB, et al. Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: an international expert position paper. Hypertension 2020;76:1368-83.
13. Omboni S, Guarda A. Impact of home blood pressure telemonitoring and blood pressure control: a meta-analysis of randomized controlled studies. Am J Hypertens 2011;24:989-98.
14. Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension 2011;57(1):29-38.
15. Verberk WJ, Kessels AG, Thien T. Telecare is a valuable tool for hypertension management, a systematic review and meta-analysis. Blood Press Monit 2011;16:149-55.
16. Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens 2013;31:455-67; discussion 467.
17. Duan Y, Xie Z, Dong F, et al. Effectiveness of home blood pressure telemonitoring: a systematic review and meta-analysis of randomised controlled studies. J Hum Hypertens 2017;31:427-37.
18. Omboni S, Tenti M, Coronetti C. Physician-pharmacist collaborative practice and telehealth may transform hypertension management. J Hum Hypertens 2019;33:177-87.
19. Tucker KL, Sheppard JP, Stevens R, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med 2017;14:e1002389.
20. Lu X, Yang H, Xia X, et al. Interactive mobile health intervention and blood pressure management in adults. Hypertension 2019;74:697-704.
21. Ma Y, Cheng HY, Cheng L, Sit JWH. The effectiveness of electronic health interventions on blood pressure control, self-care behavioural outcomes and psychosocial well-being in patients with hypertension: a systematic review and meta-analysis. Int J Nurs Stud 2019;92:27-46.
22. Stogios N, Kaur B, Huszti E, Vasanthan J, Nolan RP. Advancing digital health interventions as a clinically applied science for blood pressure reduction: a systematic review and meta-analysis. Can J Cardiol 2020;36:764-74.
23. Indraratna P, Tardo D, Yu J, et al. Mobile phone technologies in the management of ischemic heart disease, heart failure, and hypertension: systematic review and meta-analysis. JMIR Mhealth Uhealth 2020;8:e16695.
24. Khanijahani A, Akinci N, Quitiquit E. A systematic review of the role of telemedicine in blood pressure control: focus on patient engagement. Curr Hypertens Rep 2022; doi: 10.1007/s11906-022-01186-5.
25. Mikulski BS, Bellei EA, Biduski D, De Marchi ACB. Mobile health applications and medication adherence of patients with hypertension: a systematic review and meta-analysis. Am J Prev Med 2022;62:626-34.
26. Omboni S, Padwal RS, Alessa T, et al. The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future. Connect Health 2022;1:7-35.
27. Dyer O. Covid-19: pandemic is having “severe” impact on non-communicable disease care, WHO survey finds. BMJ 2020;369:m2210.
28. Laffin LJ, Kaufman HW, Chen Z, et al. Rise in blood pressure observed among US adults during the COVID-19 pandemic. Circulation 2022;145:235-7.
29. Fosco MJ, Silva P, Taborda GA, Ahumada L. Association between mandatory lockdown due to COVID-19 and severe arterial hypertension. Medicina (B Aires) 2020;80 Suppl 6:25-9.
30. Coma E, Mora N, Méndez L, et al. Primary care in the time of COVID-19: monitoring the effect of the pandemic and the lockdown measures on 34 quality of care indicators calculated for 288 primary care practices covering about 6 million people in Catalonia. BMC Fam Pract 2020;21:208.
31. Robbins CL, Ford ND, Hayes DK, et al. Clinical practice changes in monitoring hypertension early in the COVID-19 pandemic. Am J Hypertens ;2022:hpac049.
32. Taylor P, Berg C, Thompson J, et al. Effective Access to care in a crisis period: hypertension control during the COVID-19 pandemic by telemedicine. Mayo Clin Proc Innov Qual Outcomes 2022;6:19-26.
33. Girerd N, Meune C, Duarte K, Vercamer V, Lopez-Sublet M, Mourad JJ. Evidence of a blood pressure reduction during the COVID-19 pandemic and associated lockdown period: insights from e-health data. Telemed J E Health 2022;28:266-70.
34. Omboni S, Ballatore T, Rizzi F, Tomassini F, Panzeri E, Campolo L. Telehealth at scale can improve chronic disease management in the community during a pandemic: an experience at the time of COVID-19. PLoS One 2021;16:e0258015.
35. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation 2018;138:e484-594.
36. Parati G, Stergiou GS, Bilo G, et al. Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension. Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension. J Hypertens 2021;39:1742-67.
37. Gijón-Conde T, Rubio E, Gorostidi M, et al. 2021 Spanish Society of Hypertension position statement about telemedicine. Hipertens Riesgo Vasc 2021;38:186-96.
38. Khan NA, Stergiou GS, Omboni S, et al. Virtual management of hypertension: lessons from the COVID-19 pandemic-International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension. J Hypertens 2022; doi: 10.1097/HJH.0000000000003205.
39. Johnson KW, Torres Soto J, Glicksberg BS, et al. Artificial intelligence in cardiology. J Am Coll Cardiol 2018;71:2668-79.
41. Omboni S. The role of e-health in 24-h monitoring of central haemodynamics and vascular function. ARTRES 2019;25:11.
42. Mukkamala R, Stergiou GS, Avolio AP. Cuffless blood pressure measurement. Annu Rev Biomed Eng 2022;24:203-30.
43. Luo H, Yang D, Barszczyk A, et al. Smartphone-based blood pressure measurement using transdermal optical imaging technology. Circ Cardiovasc Imaging 2019;12:e008857.
44. Picone DS, Deshpande RA, Schultz MG, et al. Nonvalidated home blood pressure devices dominate the online marketplace in Australia: major implications for cardiovascular risk management. Hypertension 2020;75:1593-9.
45. Mukkamala R, Yavarimanesh M, Natarajan K, et al. Evaluation of the accuracy of cuffless blood pressure measurement devices: challenges and proposals. Hypertension 2021;78:1161-7.
46. Islam SMS, Chow CK, Daryabeygikhotbehsara R, et al. Wearable cuffless blood pressure monitoring devices: a systematic review and meta-analysis. European Heart Journal - Digital Health 2022; doi: 10.1093/ehjdh/ztac021.
47. Uddin MZ, Khaksar W, Torresen J. Ambient sensors for elderly care and independent living: a survey. Sensors (Basel) 2018;18:2027.
